AKT1 and cancer: Given the important roles of HSF1 in regulating hepatic glucose and lipid metabolism by modulating Akt activity and molecular chaperone expressions,27, 28, 50, 51 the side effects such as hyperglycaemia should be taken into consideration when HSF1 inhibitor is potentially used to treat cancers.